What are the limitations of the revised geneva score?

While the revised geneva score is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the revised geneva score to ensure safe bedside use and optimal diagnostic accuracy.

How does the revised geneva score compare to other hematology scores?

The revised geneva score is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the revised geneva score free to use?

Yes. OpiCalc provides the revised geneva score completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

Revised Geneva Score (PE)

Revised Geneva (Objective): Does not rely on clinical gestalt. High scores (≥ 11) indicate a 74% prevalence of PE and mandate immediate imaging.

1. Clinical Predictors

2. Heart Rate Assessment

Revised Geneva Score

0

Probability Class

Low Probability

~8% Prevalence

Diagnostic Action Plan

D-dimer

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessing pretest probability of Pulmonary Embolism (PE) using strictly objective variables.

Alternative to the Wells Score for clinicians who prefer a model without subjective "gestalt" components.

Risk-stratifying patients for D-dimer vs. CTPA pathways.

The 'Objective' Advantage

Unlike the Wells Score, the Geneva score does not include the clinician's opinion on alternative diagnoses, making it more standardized and less dependent on clinician experience.

Section 2

Formula & Logic

Clinical Predictors (Revised version weights)

Criterion	Points
Age > 65 years	1
Previous DVT or PE	3
Surgery (GA) or LL fracture < 1 month	2
Active Malignant Tumor	2
Unilateral Lower Limb (LL) pain	3
Hemoptysis	2
Heart Rate 75 - 94 bpm	3
Heart Rate ≥ 95 bpm	5
Pain on LL deep venous palpitation and unilateral edema	4

Interpretation

Score	Probability Level	PE Prevalence
0 - 3	Low Probability	8%
4 - 10	Intermediate Probability	28%
≥ 11	High Probability	74%

Section 3

Pearls/Pitfalls

Lower Extremity Pain

The Geneva score places significant weight on the physical findings of the lower limbs. "Unilateral LL pain" and "LL palpation pain + edema" are independent predictors totaling up to 7 points.

The 74% Barrier

Patients with a score ≥ 11 have a nearly 3-in-4 chance of having a PE. In this group, D-dimer is contraindicated; immediate therapeutic anticoagulation (if safe) and emergency imaging are mandated.

Section 4

Evidence Appraisal

Primary Strategy

Prediction of pulmonary embolism in the emergency department: the revised Geneva score.

Le Gal G et al. • Annals of Internal Medicine. 2006;144(3):165-71.

View Source

Revised Geneva Score and Wells Score for predicting pulmonary embolism in the emergency department.

Klukowska-Roetzler A et al. • Swiss Medical Weekly. 2020;Comparison of performance metrics.

View Source

Section 5

Literature

History

Developed by the Geneva University Hospital group to provide a fully standardized scoring system that could be used by junior clinicians with high reliability.

Last Comprehensive Review: 2026

Related Hematology Tools

ISTH Bleeding Assessment Tool

PBT

von Willebrand Factor Activity Interpreter

Haemophilia Severity Classification

Factor Inhibitor Bethesda Titre Interpreter

ISTH Non-Overt DIC Score

Mixing Study Interpretation

Lupus Anticoagulant

Wells Score

Have feedback about this calculator?Let us know.

Revised Geneva Score (PE)

Revised Geneva (Objective): Does not rely on clinical gestalt. High scores (≥ 11) indicate a 74% prevalence of PE and mandate immediate imaging.

1. Clinical Predictors

2. Heart Rate Assessment

Revised Geneva Score

0

Probability Class

Low Probability

~8% Prevalence

Diagnostic Action Plan

D-dimer

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessing pretest probability of Pulmonary Embolism (PE) using strictly objective variables.

Alternative to the Wells Score for clinicians who prefer a model without subjective "gestalt" components.

Risk-stratifying patients for D-dimer vs. CTPA pathways.

The 'Objective' Advantage

Unlike the Wells Score, the Geneva score does not include the clinician's opinion on alternative diagnoses, making it more standardized and less dependent on clinician experience.

Section 2

Formula & Logic

Clinical Predictors (Revised version weights)

Criterion	Points
Age > 65 years	1
Previous DVT or PE	3
Surgery (GA) or LL fracture < 1 month	2
Active Malignant Tumor	2
Unilateral Lower Limb (LL) pain	3
Hemoptysis	2
Heart Rate 75 - 94 bpm	3
Heart Rate ≥ 95 bpm	5
Pain on LL deep venous palpitation and unilateral edema	4

Interpretation

Score	Probability Level	PE Prevalence
0 - 3	Low Probability	8%
4 - 10	Intermediate Probability	28%
≥ 11	High Probability	74%

Section 3

Pearls/Pitfalls

Lower Extremity Pain

The Geneva score places significant weight on the physical findings of the lower limbs. "Unilateral LL pain" and "LL palpation pain + edema" are independent predictors totaling up to 7 points.

The 74% Barrier

Patients with a score ≥ 11 have a nearly 3-in-4 chance of having a PE. In this group, D-dimer is contraindicated; immediate therapeutic anticoagulation (if safe) and emergency imaging are mandated.

Section 4

Evidence Appraisal

Primary Strategy

Prediction of pulmonary embolism in the emergency department: the revised Geneva score.

Le Gal G et al. • Annals of Internal Medicine. 2006;144(3):165-71.

View Source

Revised Geneva Score and Wells Score for predicting pulmonary embolism in the emergency department.

Klukowska-Roetzler A et al. • Swiss Medical Weekly. 2020;Comparison of performance metrics.

View Source

Section 5

Literature

History

Developed by the Geneva University Hospital group to provide a fully standardized scoring system that could be used by junior clinicians with high reliability.

Last Comprehensive Review: 2026

Related Hematology Tools

ISTH Bleeding Assessment Tool

PBT

von Willebrand Factor Activity Interpreter

Haemophilia Severity Classification

Factor Inhibitor Bethesda Titre Interpreter

ISTH Non-Overt DIC Score

Mixing Study Interpretation

Lupus Anticoagulant

Wells Score

Have feedback about this calculator?Let us know.